模式识别受体介导的肿瘤免疫耐受参与肿瘤转移  

The Pattern Recognition Receptor-Mediated Immune Tolerance Is Involved in Tumor Metastasis

作　　者：胡卓伟[1] 杨红振[1] 

机构地区：[1]中国医学科学院北京协和医学院药物研究所,北京100050

出　　处：《生理科学进展》2010年第1期5-10,共6页Progress in Physiological Sciences

基　　金：教育部长江学者奖励基金;国家重大基础研究计划(973计划)基金(2006CB503808)资助课题

摘　　要：肿瘤细胞与宿主相互作用经历免疫警戒、免疫平衡和免疫逃逸过程,称为肿瘤免疫编辑。具有免疫逃逸能力是肿瘤细胞的标志性改变,也是肿瘤生长失控、转移和治疗失效的重要原因。病原微生物所含病原相关模式分子和肿瘤组织释放的损伤相关模式分子与肿瘤细胞及周围组织细胞和免疫细胞表达的模式识别受体相互作用,引起抑制性免疫微环境是导致肿瘤免疫耐受的关键。以肿瘤免疫耐受为药靶,使用小分子化合物或具有免疫刺激活性的生物制剂如单克隆抗体,可逆转肿瘤抑制性免疫微环境,打破肿瘤免疫耐受,抑制肿瘤细胞的生长和侵袭能力,从而降低肿瘤细胞转移和肿瘤致死率。The interaction of tumor cells with host cells undergoes a progress of immunoediting, including surveillance, equilibrium and escape. The capability of escape from immune-surveillance is a hall marker of tumor cells, which greatly contributes to the tumor growth out of control and the therapy failure in tumor metastasis. It is indicated that tumor cells can recruit amounts of immune cells to tumor site and establish a suppressive immune microenvironment leading to tumor escape. The critical factor for tumor immunotolerance is the establishment of immunosuppressive microenvironment by interaction between pattern recognition receptors with pathogen-associated molecular patterns and damage-associated molecular patterns released from tumor tissue. Therefore, targeting tumor immunotolerance using small molecules or immunostimulatory biological agents such as monoclonal antibody, can inhibit tumor growth and invasion, and subsequently attenuate the tumor metastasis and decrease cancer-caused death.

关 键 词：免疫耐受 抑制性免疫微环境 免疫治疗 模式识别受体 TOLL样受体 

分 类 号：R575[医药卫生—消化系统]